Immune suppression in polymicrobial sepsis: Differential regulation of Th1 and Th2 responses by p38 MAPK

Journal of Surgical Research

Volumn 91, Issue 2, 2000, Pages 141-146

  Song, Grace Y ^a   Chung, Chun Shiang ^a   Chaudry, Irshad H ^a   Ayala, Alfred ^a  

^a BROWN UNIVERSITY   (United States)

Author keywords

Cecal ligation and puncture; ERK; JNK SAPK; Mouse; P38 MAPK; Splenocytes

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; DIMETHYL SULFOXIDE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 2; MITOGEN ACTIVATED PROTEIN KINASE; SYNAPTOPHYSIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; CONFERENCE PAPER; CONTROLLED STUDY; CYTOKINE RELEASE; HELPER CELL; IMMUNE DEFICIENCY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM; SEPSIS; SPLEEN LYMPHOCYTE;

EID: 0034659411     PISSN: 00224804     EISSN: None     Source Type: Journal    
DOI: 10.1006/jsre.2000.5928     Document Type: Conference Paper

References (26)

1. Song G. Y., Chung C. S., Chaudry I. H., Ayala A. What is IL-10's role in polymicrobial sepsis: Anti-inflammatory agent or immune suppressant? Surgery. 126:1999;378.
2. Ayala A., Deol Z. K., Lehman D. L., Herdon C. D., Chaudry I. H. Polymicrobial sepsis but not low dose endotoxin infusion causes decreased splenocyte IL-2/IFN-gamma release while increasing IL-4/IL-10 production. J. Surg. Res. 56:1994;579.
3. O'Sullivan S. T., Lederer J. A., Horgan A. F., Chin D. H. L., Mannick J. A., Rodrick M. L. Major injury leads to predominance of the T helper-2 lymphocyte phenotype and diminished interleukin-12 production associated with decreased resistance to infection. Ann. Surg. 222:1995;482.
4. DiPiro J. T., Howdieshell T. R., Goddard J. K., Callaywa D. B., Hamilton R. G., Mansberger A. R. Association of interleukin-4 plasma levels with traumatic injury and clinical course. Arch. Surg. 130:1998;1159.
5. Mathews J. S., O'Neill L. A. Distinct roles for p42/p44 and p38 mitogen-activated protein kinases in the induction of IL-2 by IL-1. Cytokine. 11:1999;643.
6. Chen C. Y., Del Gatto-Konczak F., Wu Z., Karin M. Stabilization of interleukin-2 mRNA by the c-Jun NH2-terminal kinase pathway. Science. 280:1998;1945.
7. Matsuda S., Moriguchi T., Koyasu S., Nishida E. T lymphocyte activation signals for interleukin-2 production involve activation of MKK6-p38 and MKK7-SAPK/JNK signaling pathways sensitive to cyclosporin A. J. Biol. Chem. 273:1998;12378.
8. Nishina H., Bachmann M., Oliveira-dos-Santos A. J., Kozieradzki I., Fischer K. D., Odermatt B., Wakeham A., Shahinian A., Takimoto H., Bernstein A., Mak T. W., Woodgett J. R., Ohashi P. S., Penninger J. M. Impaired CD28-mediated interleukin 2 production and proliferation in stress kinase SAPK/ERK1 kinase (SEK1)/mitogen-activated protein kinase kinase 4 (MKK4)-deficient T lymphocytes. J. Exp. Med. 186:1997;941.
9. DeSilva D. R., Jones E. A., Favata M. F., Jaffee B. D., Magolda R. L., Trzaskos J. M., Scherle P. A. Inhibition of mitogen-activated protein kinase kinase blocks T cell proliferation but does not induce or prevent anergy. J. Immunol. 160:1998;4175.
10. Lee J. C., Laydon J. T., McDonnell P. C., Gallagher T. F., Kumar S., Green D., McNulty D., Blumenthal M. J., Heys J. R., Landvatter S. W., Strickler J. E., McLaughlin M. M., Siemens I. R., Fiser S. M., Livi G. P., White J. R., Adams J. L., Young P. R. A protein kinase involved in the regulation of inflammatory cytokine biosynthesis. Nature. 372:1994;739.
11. Gallagher T. F., Seibel G. L., Kassis S., Laydon J. T., Blumenthal M. J., Lee J. C., Lee D., Boehm J. C., Fier-Thompson S. M., Abt J. W., Soreson M. E., Smietana J. M., Hall R. F., Garigipati R. S., Bender P. E., Erhard K. F., Krog A. J., Hofmann G. A., Sheldrake P. L., McDonnell P. C., Kumar S., Young P. R., Adams J. L. Regulation of stress-induced cytokine production by pyridinylimidazoles: Inhibition of CSBP kinase. Bioorg. Med. Chem. 5:1997;49.
12. Badger A. M., Bradbeer J. N., Votta B., Lee J. C., Adams J. L., Griswold D. E. Pharmacological profile of SB203580, a selective inhibitor of cytokine suppressive binding protein/p38 kinase, in animal models of arthritis, bone resorption, endotoxin shock and immune function. J. Pharmacol. Exp. Ther. 279:1995;1453.
13. Koprak S., Staruch M. J., Dumont F. J. A specific inhibitor of the p38 mitogen activated protein kinase affects differentially the production of various cytokines by activated human T cells: Dependence on CD28 signaling and preferential inhibition of IL-10 production. Cell. Immunol. 192:1999;87.
14. Sugawara T., Moriguchi T., Nishida E., Takahama Y. Differential roles of ERK and p38 MAP kinase pathways in positive and negative selection of T lymphocytes. Immunity. 9:1998;565.
15. DeSilva D. R., Jones E. A., Feeser W. S., Manos E. J., Scherle P. A. The p38 mitogen-activated protein kinase pathway in activated and anergic Th1 cells. Cell. Immunol. 180:1997;116.
16. Hunt A. E., Lali F. V., Lord J. D., Nelson B. H., Miyazaki T., Tracey K. J., Foxwell B. M. J. Role of interleukin (IL)-2 receptor beta-chain subdomains and Shc in p38 mitogen-activated protein (MAP) kinase and p54 MAP kinase (stress-activated protein kinase/c-Jun N-terminal kinase) activation. J. Biol. Chem. 274:1999;7591.
17. Baker C. C., Chaudry I. H., Gaines H. O., Baue A. E. Evaluation of factors affecting mortality rate after sepsis in murine cecal ligation and puncture model. Surgery. 94:1983;331.
18. Ayala A., Perrin M. M., Kisala J. M., Ertel W., Chaudry I. H. Polymicrobial sepsis selectively activates peritoneal but not alveolar macrophage to release inflammatory mediators (IL-1, IL-6 and TNF). Circ. Shock. 36:1992;191.
19. Mannick J. A. Trauma, sepsis and immune defects. Faist E., Meakins J. L., Schildberg F. W. Host Defense Dysfunction in Trauma, Shock and Sepsis. 1993;15-21 Springer-Verlag, Berlin.
20. Baue A. E. Multiple Organ Failure. Patient Care and Prevention. 1990;Mosby, St. Louis.
21. Ayala A., Deol Z. K., Lehman D. L., Herdon C. D., Chaudry I. H. Does endotoxin play a major role in inducing the depression of macrophage function during polymicrobial sepsis? Arch. Surg. 130:1995;1178.
22. Ertel W., Morrison M. H., Wang P., Ba Z. F., Ayala A., Chaudry I. H. The complex pattern of cytokines in sepsis: Association between prostaglandins, cachectin and interleukins. Ann. Surg. 214:1991;141.
23. Hadjiminas D. J., McMasters K. M., Peyton J. C., Cheadle W. G. Tissue tumor necrosis factor mRNA expression following cecal ligation and puncture or intraperitoneal injection of endotoxin. J. Surg. Res. 56:1994;549.
24. Ayala A., Knotts J. B., Ertel W., Perrin M. M., Morrison M. H., Chaudry I. H. Role of interleukin 6 and transforming growth factor-beta in the induction of depressed splenocyte responses following sepsis. Arch. Surg. 128:1993;89.
25. Marshall L. A., Hansbury M. J., Bolognese B. J., Gum R. J., Young P. R., Mayer R. J. Inhibitors of the p38 mitogen-activated kinase modulate IL-4 induction of low affinity IgE receptor (CD23) in human monocytes. J. Immunol. 161:1999;6005.
26. Song G. Y., Chung C. S., Schwacha M. G., Jarrar D., Chaudry I. H., Ayala A. Splenic immune suppression in sepsis: A role for IL-10 induced changes in P38 MAPK signaling. J. Surg. Res. 83:1999;36.